论文部分内容阅读
作者研究了347例高危表浅性膀胱肿瘤(高级别T_a及T_l肿瘤伴原位癌)患者,在接受连续6周的BCG膀胱灌注治疗前,132例进行了单次经尿道电切术(TUR),215例进行了再次分期TUR。根据患者术后首次膀胱镜复查、术后6和12个月复查结果评价疗效,并根据3年内的随访结果评价疾病的进展情况。结果显示,在接受单次TUR的132
The authors studied 347 patients with high-risk superficial bladder tumors (high-grade T_a and T_l tumors with carcinoma in situ) who had undergone a single transurethral resection (TUR) before being treated with BCG for 6 weeks ), 215 cases were re-staging TUR. According to the first postoperative cystoscopy review, 6 and 12 months after the review of the results to evaluate the efficacy and follow-up results within 3 years to evaluate the progress of the disease. The results showed that in receiving a single TUR 132